Parenteral drug products should be visually inspected for particulate matter and discoloration prior to administration, whenever the solution and container permit
The 1-3 mg/mL range described in most community protocols sits in the comfortable middle
The World Anti-Doping Agency added BPC-157 to its Prohibited List in January 2022 under category S0 (Non-Approved Substances)
Current Pharmaceutical Design , 2020 In various studies, BPC-157 was observed to: Accelerate healing of muscle, tendon, ligament, nerve, and gut tissue Reduce inflammation, fibrosis, and oxidative stress Protect organ systems (gut, liver, brain) under chemical or surgical stress Stabilize blood vessels and prevent internal bleeding in injury models Importantly, these effects occurred without toxicity , even when administered in high or repeated doses